GARTX | SMUYX | GARTX / SMUYX | |
Total Expense Ratio | 1.10 | 1.09 | 101% |
Annual Report Gross Expense Ratio | 1.19 | 3.47 | 34% |
Fund Existence | 17 years | 10 years | - |
Gain YTD | 8.290 | 7.725 | 107% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.44B | 241M | 2,258% |
Annual Yield % from dividends | 0.75 | 5.43 | 14% |
Returns for 1 year | 8.03 | 7.83 | 103% |
Returns for 3 years | 29.65 | 26.00 | 114% |
Returns for 5 years | 19.47 | 16.49 | 118% |
Returns for 10 years | 27.47 | 29.05 | 95% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TFEQX | 12.87 | N/A | N/A |
Templeton Instl Intl Eq Ser Primary | |||
HFCVX | 22.96 | N/A | N/A |
Hennessy Cornerstone Value Investor | |||
FBTDX | 136.56 | N/A | N/A |
Franklin Biotechnology Discovery C | |||
FGJMX | 142.56 | N/A | N/A |
Fidelity Advisor Communication ServicesI | |||
MLRRX | 12.72 | -0.08 | -0.62% |
NYLI Winslow Large Cap Growth Class R1 |